1. Home
  2. Clinical Topics
  3. FDA restricts patient access to rosiglitazone
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA restricts patient access to rosiglitazone

Share

The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll in a special program in order to prescribe the medicines, and patients must enroll in the same program in order to obtain their medicines through the mail. After November 18, 2011, rosiglitazone-containing medicines will no longer be available through retail pharmacies. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll

Recent Posts